Referat Kieger AG
Thursday, 28. April 2022, 14:00 - 14:40 UHR
Seminarraum 4
Deutsch
Speaker(s): Urban Fritsche, Dr. Maria Specogna
Lead PM Kieger Impact Healthcare Fund, Kieger AG
Urban Fritsche is Portfolio Manager in the Healthcare team. He co-manages Healthcare equity funds focused on thematic impact (lead manager), sustainability and blue-chip stocks. He is a member of the Management Committee.
He has worked in the financial industry for many years, focusing primarily on the Pharmaceutical sector. Before joining Kieger, he worked for BZ Bank in Wollerau as sell-side analyst covering the Pharmaceutical, MedTech and Chemical sectors. In the earlier part of his career, he was brand manager for knee implants at Zimmer Biomet in Winterthur and, before that, project manager at Prionics (now Thermo Fisher Scientific) in Zurich.
Urban studied Business Administration at the University of St. Gallen. He also holds a Master of Science in Biotechnology from the Technical University of Zurich.
Lead PM Kieger Sustainable Healthcare Fund, Kieger AG
Maria Specogna is Portfolio Manager in the Healthcare team. She manages Healthcare equity funds focused on sustainability (lead manager), thematic impact and blue-chip stocks. She is Advisor to Sustainable Investing and a member of the Management Committee.
She has 20 years of experience in the financial industry, of which 16 in the field of sustainable investments. Prior to joining Kieger, she was responsible for Healthcare investments at Vontobel Asset Management. Before that, she co-developed and implemented ESG-integration strategies for equity analysis at both Vontobel Asset Management and Swiss Re, significantly improving their performance track-record. During the 6 years prior to her move to Swiss Re in 2007, she worked for Credit Suisse Private Bank, where she was responsible for Healthcare and Chemicals research. Her early professional years, following her studies, were spent as research scientist at the Institute of Physiology of the University of Zurich and as Laboratory Head at Givaudan.
Maria studied Biochemistry and holds a PhD from the University of Zurich. She also obtained the Swiss Financial Analyst certification delivered by AZEK (Swiss Training Centre for Investment Professionals)
